JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

Vivani Medical

Cerrado

1.6 -0.62

Resumen

Variación precio

24h

Actual

Mínimo

1.5699999999999998

Máximo

1.6

Métricas clave

By Trading Economics

Empleados

37

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+146.91% upside

Dividendos

By Dow Jones

Próximas Ganancias

12 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

26M

90M

Apertura anterior

2.22

Cierre anterior

1.6

Vivani Medical Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

26 oct 2025, 23:52 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

26 oct 2025, 23:52 UTC

Charlas de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

26 oct 2025, 23:46 UTC

Charlas de Mercado

Oil Rises Amid Ongoing Supply Concerns -- Market Talk

26 oct 2025, 23:41 UTC

Charlas de Mercado

Gold Falls; U.S.-China Trade Deal Optimism Overcomes Signs of Cooler U.S. Inflation -- Market Talk

26 oct 2025, 23:34 UTC

Ganancias

Sinopharm Group 9-Mos Oper Pft CNY10.87B Vs. Pft CNY10.84B >1099.HK

26 oct 2025, 23:32 UTC

Ganancias

Sinopharm Group 9-Mos Net CNY5.31B Vs. Net CNY5.28B >1099.HK

26 oct 2025, 23:30 UTC

Ganancias

Sinopharm Group 9-Mos Rev CNY431.48B Vs. CNY442.42B >1099.HK

26 oct 2025, 22:29 UTC

Ganancias

WuXi AppTec 3Q Rev CNY12.06B ; up 15.3% on Year>603259.SH

26 oct 2025, 22:29 UTC

Ganancias

WuXi AppTec: Higher Contributions From Contract Research Development and Manufacturing Organization Unit Supported Results>603259.SH

26 oct 2025, 22:29 UTC

Ganancias

WuXi AppTec: Results Also Boosted From Divestment Gains >603259.SH

26 oct 2025, 22:29 UTC

Ganancias

WuXi AppTec 3Q Net CNY5.13B ; up 82.9% on Year>603259.SH

26 oct 2025, 22:16 UTC

Ganancias

Stock Futures Rise Ahead of Mag 7 Earnings, Fed Decision -- Barrons.com

26 oct 2025, 21:33 UTC

Adquisiciones, fusiones, absorciones

Novartis Agrees to Acquire Avidity Biosciences for $12 Billion -- WSJ

26 oct 2025, 19:29 UTC

Adquisiciones, fusiones, absorciones

Novartis Deal Values Avidity Biosciences At $12 Billion -- Barrons.com

26 oct 2025, 06:39 UTC

Ganancias

CITIC Securities 3Q Rev CNY22.78B Vs. CNY15.96B >6030.HK

26 oct 2025, 06:39 UTC

Ganancias

CITIC Securities: Higher Income From Brokerage, Investment Banking Supported Results>6030.HK

26 oct 2025, 06:39 UTC

Ganancias

CITIC Securities 3Q Net CNY9.44B Vs. Net CNY6.23B >6030.HK

24 oct 2025, 21:24 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

24 oct 2025, 21:24 UTC

Charlas de Mercado

Moody's Sees France With Increased Risk of Political Dysfunction -- Market Talk

24 oct 2025, 21:07 UTC

Ganancias

The Score: Netflix, Amazon.com, Six Flags and More Stocks That Defined the Week -- WSJ

24 oct 2025, 20:58 UTC

Ganancias

S&P 500 Climbs to New Record on Strong Earnings -- WSJ

24 oct 2025, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

24 oct 2025, 20:40 UTC

Ganancias

Intel Expects Chip Shortages on Better PC Demand. Here's Why AMD Is Winning Too. -- Barrons.com

24 oct 2025, 20:24 UTC

Ganancias

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

24 oct 2025, 20:23 UTC

Ganancias

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

24 oct 2025, 20:13 UTC

Ganancias

These Stocks Moved the Most Today: Intel, AMD, Ford, Deckers, Newmont, Nextracker, Booz Allen, Coinbase, and More -- Barrons.com

24 oct 2025, 20:07 UTC

Charlas de Mercado

Different-Cell Imputation Rose Proportionally in September CPI -- Market Talk

24 oct 2025, 19:40 UTC

Charlas de Mercado

Treasury Yields Mixed, Dollar Stronger Ahead of Fed Week -- Market Talk

24 oct 2025, 19:35 UTC

Charlas de Mercado

Oil Rally on U.S. Russia Sanctions Loses Steam -- Market Talk

24 oct 2025, 19:33 UTC

Ganancias

IBM and Google Are Also Making Moves in Quantum. Don't Count Out the Bigger Players. -- Barrons.com

Comparación entre iguales

Cambio de precio

Vivani Medical Esperado

Precio Objetivo

By TipRanks

146.91% repunte

Estimación a 12 meses

Media 4 USD  146.91%

Máximo 4 USD

Mínimo 4 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Vivani Medical Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

2

Comprar

0

Mantener

0

Vender

Finanzas

$

Acerca de Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.
help-icon Live chat